Gemfibrozil

Primary Uses

Gemfibrozil is primarily prescribed to treat the following conditions:

• Very high triglyceride levels: It is used in adults with severely elevated triglycerides (fats) to help reduce the risk of pancreatitis, which is a painful inflammation of the pancreas.
• Heart disease risk reduction: It may be used to lower the risk of coronary heart disease in specific patients who have high "bad" cholesterol (LDL), high triglycerides, and low "good" cholesterol (HDL).

When It Is Prescribed

Healthcare providers typically prescribe gemfibrozil when other treatments or lifestyle modifications have not been effective enough. These include:

• Dietary changes specifically aimed at lowering fat and cholesterol intake.
• Weight loss and regular physical activity.
• Other medications that were either not tolerated or did not achieve the target cholesterol levels.

This medication is intended to be used as part of a total treatment program that includes a heart-healthy diet and exercise.

How Gemfibrozil Works

Gemfibrozil belongs to a class of medications known as fibrates. It is primarily used to regulate the levels of lipids (fats) in the blood by decreasing the production of certain fats and increasing the body's ability to remove them.

While the exact mechanism is not fully established, the medication is believed to work in the following ways:

• Inhibiting fat production: It reduces the liver's production of triglycerides and very-low-density lipoprotein (VLDL) cholesterol. VLDL is a type of cholesterol that carries high amounts of triglycerides.
• Enhancing fat clearance: It stimulates the activity of an enzyme called lipoprotein lipase. This enzyme helps break down and clear triglycerides from the bloodstream.
• Increasing good cholesterol: It helps raise levels of high-density lipoprotein (HDL), often called "good" cholesterol, which helps transport other forms of cholesterol out of the blood vessels.

By lowering high triglyceride levels, gemfibrozil can help reduce the risk of developing pancreatitis, a serious inflammation of the pancreas.

Common Side Effects

Gemfibrozil may cause mild side effects as the body adjusts to the medication. Frequently reported symptoms include:

• Stomach pain, gas, or heartburn
• Nausea or vomiting
• Diarrhea or constipation
• Headache
• Dizziness
• Fatigue
• Muscle or joint pain
• Changes in the sense of taste

Serious Side Effects

While less common, some side effects can be severe and require immediate medical attention. Contact a healthcare provider right away if you experience:

• Muscle Damage: Unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or unusual tiredness. This may indicate a serious condition called rhabdomyolysis.
• Gallbladder Problems: Severe pain in the upper stomach area (often after eating), which may spread to the back or shoulder and be accompanied by nausea.
• Liver Issues: Yellowing of the skin or eyes (jaundice), dark-colored urine, or persistent pain in the upper right side of the stomach.
• Kidney Problems: Significant changes in how much or how often you urinate.
• Allergic Reactions: Severe skin rash, hives, swelling of the face, lips, or throat, and difficulty breathing or swallowing.
• Blood Disorders: Unusual bruising or bleeding, or signs of infection such as a persistent sore throat and fever.

Muscle and Kidney Risks

Gemfibrozil can cause muscle pain, tenderness, or weakness, a condition known as myopathy. In severe cases, this can lead to rhabdomyolysis, a serious condition where muscle tissue breaks down and may cause kidney damage. This risk is significantly higher if gemfibrozil is taken with certain cholesterol-lowering medications called statins.

Gallbladder and Liver Health

This medication may increase the amount of cholesterol in the bile, which can lead to the formation of gallstones. If gallstones are suspected, diagnostic testing is usually required. Additionally, gemfibrozil can affect liver function, and healthcare providers typically monitor liver enzyme levels during treatment.

Contraindications

Gemfibrozil is generally not recommended for individuals with the following conditions:

• Severe kidney disease or impairment.
• Liver disease, including primary biliary cirrhosis.
• Pre-existing gallbladder disease.
• A known hypersensitivity to gemfibrozil.

Drug Interactions

Certain medications should not be taken with gemfibrozil due to the risk of severe side effects. These include:

• Simvastatin: Combining these drugs increases the risk of muscle damage.
• Repaglinide: This combination can cause a dangerous drop in blood sugar levels (hypoglycemia).
• Warfarin: Gemfibrozil may increase the effects of blood thinners, requiring careful monitoring of blood clotting times.

Monitoring

Regular blood tests are often necessary to check liver function, kidney function, and blood cell counts (such as white blood cells and hemoglobin) while taking this medication.

Pregnancy

There are no adequate and well-controlled studies on the use of gemfibrozil in pregnant women. In animal studies, high doses of the medication were associated with adverse effects on the fetus. Because the safety of this medication during pregnancy has not been established, it should only be used if a healthcare provider determines that the potential benefit to the mother justifies the potential risk to the developing fetus.

Breastfeeding

It is not known whether gemfibrozil passes into human breast milk. Because many drugs are excreted in milk and there is a potential for serious adverse reactions in nursing infants, healthcare providers typically recommend either discontinuing breastfeeding or discontinuing the medication. This decision is based on the importance of the drug to the mother's health.

Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment options and the potential risks with their clinical team before using gemfibrozil.

Dosage Forms

Gemfibrozil is produced for oral use. It is available in the following form:

• Oral Tablet: This medication is taken by mouth as directed by a healthcare professional.

Gemfibrozil is available as a generic medication and under the brand name Lopid.

FDA Approval and Indications

Gemfibrozil was first approved by the U.S. Food and Drug Administration (FDA) in 1981. It is indicated as adjunctive therapy to diet for the following conditions:

• Treatment of adult patients with very high elevations of serum triglyceride levels (Type IV or V hyperlipidemia) who are at risk of pancreatitis and do not respond adequately to dietary effort.
• Reducing the risk of developing coronary heart disease in Type IIb patients who have low HDL-cholesterol and have not responded to other treatments.

Regulatory Warnings and Safety Communications

The FDA has issued safety communications regarding the use of gemfibrozil in combination with certain HMG-CoA reductase inhibitors (statins). Specifically, the FDA updated statin labels to warn that gemfibrozil should be avoided with simvastatin and restricted with other statins due to a significantly increased risk of rhabdomyolysis, a serious condition involving muscle breakdown.

Gemfibrozil is also contraindicated for use with certain other medications, such as repaglinide and dasabuvir, due to the potential for severe drug interactions. Labeling also includes warnings regarding the potential for increased risk of gallbladder stones (cholelithiasis).

Controlled Substance Status

Gemfibrozil is not a controlled substance. It is available only by prescription and is not subject to the Controlled Substances Act.

Gemfibrozil is primarily used to lower high levels of triglycerides (fats) in the blood. Alcohol consumption can significantly raise triglyceride levels, which may counteract the benefits of the medication. Healthcare providers typically recommend limiting or avoiding alcohol as part of the dietary changes required during treatment.

There are several reasons to be cautious about mixing gemfibrozil and alcohol:

• Triglyceride management: Because alcohol increases the amount of fat in the blood, it can make it harder for gemfibrozil to work effectively.
• Liver health: Both gemfibrozil and excessive alcohol use can affect liver function. Combining them may increase the risk of liver irritation or damage.
• Pancreatitis risk: Very high triglyceride levels can lead to pancreatitis (inflammation of the pancreas). Since alcohol raises triglycerides, it may indirectly increase this risk in people already prone to high fat levels.

It is important to talk to a doctor about how much alcohol, if any, is safe to consume while taking this medication.